Alan Moss
Director, Crohn's & Colitis Program, Boston Medical Center · Beth Israel Deaconess Medical Center
Credentials: · · · · · ·
History
- 1993–1997
Research
Gastroenterology · 2011 · First of 10 authors · 482 citations
Review · Mayo Clinic Proceedings · 2019 · 335 citations
Systematic review or meta-analysis · The American Journal of Gastroenterology · 2013 · Last of 3 authors · 295 citations
45 papers · 8 as a fellow
20 papers
10 papers · 8 as a resident
9 papers · 6 as a fellow
7 papers · 6 as a resident
7 papers · 5 as a resident
7 papers · 7 as a resident
6 papers · 6 as a resident
Grants
- 2015–2018
Significance of Luminal Exosomes in Inflammatory Bowel Disease (IBD)
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $174K · Beth Israel Deaconess Medical Center
- 2011–2017
Purinergic Pathways in Crohn's Disease
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $735.1K · Beth Israel Deaconess Medical Center
Clinical trials
- 2015–2021
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
Principal investigator · Terminated · Phase 2
Boston Medical Center
- 2013–2016
Principal investigator · Completed · Phase 1
Beth Israel Deaconess Medical Center
- 2012–2015
Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
Principal investigator · Completed
Beth Israel Deaconess Medical Center
- 2011–2012
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease
Principal investigator · Completed
Beth Israel Deaconess Medical Center